FormWeb • Black Box Warning

Genesis Health

Approved Formulary

Hospital Homepage Questions about the Formulary?
Click on this link to email us. Formulary Addition Request
Latex-free Medications -
Username:genesis
Password: latexinfo987

Webpage Links

Add Formweb to your mobile device

Android iOS

Our Department Mission....Delivering Excellence and Trust in Pharmaceutical Care through a Culture of Precision.

Genesis Health

Approved Formulary

Hospital Homepage Questions about the Formulary?
Click on this link to email us. Formulary Addition Request
Latex-free Medications -
Username:genesis
Password: latexinfo987

Black Box Warning

Please review each of these drugs carefully.

ACETAMINOPHEN	Hepatic Toxicity
ACETAMINOPHEN IV (NONFORMULARY)	Hepatic Toxicity
ACETAMINOPHEN-CODEINE	Addiction, Abuse, And Misuse; Life-Threatening Respiratory Depression; Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants
ACETAMINOPHEN-TRAMADOL	Addiction , Abuse, and Misuse; Life-Threatening Respiratory Depression; Accidential Ingestion; Neonatal Opioid Withdrawal Syndrome; Interation with Drugs Affecting Cytochrome P450 Isoenzymes; and Risks From Concomitant Use With CNS Depressans
ADALIMUMAB	Risk of Infection
ALDESLEUKIN	Capillary Leak Syndrome
ALFENTANIL	Addiction, Abuse, and Misuse
ALISKIREN	Pregnancy
ALOSETRON	Gastrointestinal
ALPRAZOLAM	Risk From Concomitant Use With Opioids
ALPROSTADIL	Apnea
ALTRETAMINE	Neurotoxicity/Hematological Toxicity
ALVIMOPAN	Short term use in hospitals enrolled in REMS program
AMIKACIN	Neurotoxicity/Nephrotoxicity
AMILORIDE	Hyperkalemia
AMIODARONE	Arrhythmias/Pneumonitis
AMITRIPTYLINE	Suicide Ideation
AMLODIPINE	Prescribing information
AMLODIPINE-BENAZEPRIL	Prescribing information
AMOXAPINE	Suicide Ideation
AMPHETAMINE-DEXTROAMPHETAMINE	Dependence/Diversion Potential
AMPHOTERICIN B	Noninvasive Fungal Disease/Avoid Overdose
ANTIHEMOPHILIC FACTOR	Blood Derived Product Risk
APIXABAN	Increased risk of stroke upon discontiuation
ARFORMOTEROL - NONFORMULARY	Increase in asthma-related deaths
ARIPIPRAZOLE	Increase mortality in elderly patients
ASPARAGINASE
ATENOLOL	Avoid abrupt withdrawal
ATOMOXETINE	Suicidal Ideation
ATRACURIUM	Administer by Trained Personnel
AURANOFIN	Gold Toxicity
AZATHIOPRINE	Risk of Neoplasm, Infection
BACITRACIN	Nephrotoxicity (IM administration)
BACLOFEN	Abrupt Discontinuation of Intrathecal Administration
BECAPLERMIN (TOPICAL)	Increased risk of mortality secondary to malignancy
BENAZEPRIL (NONFORMULARY)	Use in Pregnancy
BEVACIZUMAB	GI Peforation/Wound Healing
BLEOMYCIN	Pulmonary Fibrosis; Idiosyncratic Reactions
BUDESONIDE INHALATION (NON FORMULARY)	Transfer from oral to inhaled steroid may require supplemental oral steroids
BUDESONIDE/FORMOTEROL - NONFORMULARY	Increased risk of death
BUMETANIDE	Profound Diuresis
BUPIVACAINE	Cardiac Arrest (intravascular injection), caution with 0.75%
BUPRENORHINE TRANSDERMAL	Potential for Abuse
BUPROPION	Suicidal Ideation
BUSULFAN	Bone Marrow Suppression
BUTORPHANOL	Addiction, Abuse, And Misuse; Life-Threatening Respiratory Depression; Neonatal Opioid Withdrawal Syndrome; and Risks From Concomitant Use With Benzodiazepines
CANDESARTAN (NONFORMULARY)	Pregnancy
CAPREOMYCIN	Black Box Warning
CAPTOPRIL	Pregnancy
CARBAMAZEPINE	Aplastic Anemia/Agranulocytosis Risk
CARBONYL IRON - NONFORMULARY
CARBOPLATIN	Myelosuppression/Anaphylaxis risk
CARMUSTINE	Bone Marrow Suppression/Pulmonary Toxicity
CELECOXIB	Increased Cardiovascular Risk
CETUXIMAB	Severe Infusion Reactions
CHLORAMBUCIL	Bone Marrow Suppression/Teratogenic
CHLORAMPHENICOL	Fatal Blood Dyscrasias
CHLORDIAZEPOXIDE	Risk From Concomitant Use With Opioids
CHLORDIAZEPOXIDE-CLIDINIUM	Risk From Concomitant Use With Opioids
CHLOROQUINE	Experienced physicians only
CHLORPROMAZINE	Increased risk of mortality in elderly
CIDOFOVIR	Nephrotoxicity/Neutropenia
CILOSTAZOL	Contraindicated with CHF (decreased survival)
CIPROFLOXACIN - ORAL AND IV ARE NONFORMULARY	Increased risk of tendonitis and tendon rupture
CISPLATIN	Nephrotoxicity, myelosuppression
CITALOPRAM	Suicidal Thoughts and Behaviors
CLADRIBINE	Bone marrow suppression, Neurotoxicity, Nephrotoxicity
CLINDAMYCIN	Pseudomembranous Colitis
CLOMIPRAMINE	Suicide Ideation
CLONAZEPAM	Risk From Concomitant Use With Opioids
CLOPIDOGREL	Decreased effectiveness in poor metabolizers
CLORAZEPATE	Risk From Concomitant Use With Opioids
CLOZAPINE	Agranulocytosis, myocarditix, seizure risk
COAGULATION FACTOR VIIA	Thrombotic Adverse Events when used off label
CODEINE	Contradindicated in children post op tonsillectomy or adenoidectomy
CONJUGATED ESTROGENS	Increased risk endometrial cancer
CONJUGATED ESTROGENS-MEDROXYPROGESTERONE	Increased CV Risk and Increased Risk of Dementia
CYCLOSPORINE	Infection, neoplasm, nephrotoxicity
CYTARABINE	Experienced physician
DABIGATRAN	Increased risk of stroke upon discontinuation without continuous anticoagulation
DACARBAZINE	Hemopoietic Disease, Risk of hepatic necrosis
DACLIZUMAB	Administration by qualified personnel
DACTINOMYCIN	Handling precautions, extravasation risk
DALFOPRISTIN-QUINUPRISTIN - RESTRICTED	Accelerated approved for life threatening VREF
DALTEPARIN - NONFORMULARY	Spinal/Epidural hematoma risk
DANAZOL	Thrombotic Event Risk/Contraindicated Pregnancy
DANTROLENE	Hepatic Risk
DARBEPOETIN ALFA	Arterial and Venous Thromboembolic Risk
DAUNORUBICIN CITRATE (LIPOSOMAL)	Cardiac, Myelosuppression, Extravasation Risk
DAUNORUBICIN HYDROCHLORIDE	Cardiac, Myelosuppression, Extravasation Risk
DEFERASIROX	Renal/hepatic failure and/or GI Hemorrhage
DESIPRAMINE	Suicidal Ideation
DESVENLAFAXINE	Suicide Ideation
DEXMETHYLPHENIDATE	Dependence/Diversion Potential
DEXTROAMPHETAMINE	Dependence/Diversion Potential
DIAZEPAM	0
DICLOFENAC	NSAID Cardiovascular Risk
DICLOFENAC-MISOPROSTOL	Pregnancy Risk
DIDANOSINE	Pancreatitis, Hepatotoxicity, Lactic Acidosis Risk
DIFLUNISAL	NSAID Cardiovascular Risk
DIHYDROERGOTAMINE	Drug Interaction List
DINOPROSTONE TOPICAL	Suppository: Recommended dose
DISOPYRAMIDE	Mortality Risk
DISULFIRAM	Administer with patient consent
DIVALPROEX SODIUM	Pancreatitis, Hepatitis, Teratogenic risk
DOCETAXEL	Hepatic Dysfunction, Hypersensitivity Risk
DOFETILIDE	Renal Function adjustment, Baseline & continuous ECG
DOPAMINE	Extravasation
DOXEPIN	Suicidal Ideation
DOXORUBICIN	Cardiac, Hepatic, Myelosuppression, Extravasation Risk
DOXORUBICIN LIPOSOMAL	Cardiac, Hepatic, Myelosuppression, Extravasation Risk
DRONEDARONE	Increased risk of death/stroke/heart failure with decompensated heart failure or permanent atrial fib
DROPERIDOL	Prolonged QT interval, cardiac risk
DULOXETINE	Suicide Ideation in Adolescents and Children
EDETATE CALCIUM DISODIUM	Lead Encephalopathy Risk
ENALAPRIL	Pregnancy
ENALAPRIL-HYDROCHLOROTHIAZIDE	Pregnancy
ENOXAPARIN	Spinal/Epidural hematoma risk
EPOETIN ALFA	Arterial and Venous Thromboembolic Risk
ESCITALOPRAM	Suicidal ideation in adolescents and children
ESTAZOLAM	Risk From Concomitant Use With Opioids
ESTERIFIED ESTROGENS-METHYLTESTOSTERONE	Increased CV and Endometrial Cancer risks
ESTRADIOL	Increased CV and Endometrial Cancer Risk
ESTRADIOL TOPICAL	Increased CV and Endometrial Cancer Risk
ETANERCEPT	Risk of infections
ETHACRYNIC ACID	Profund Diuresis
ETODOLAC	NSAID Cardiovascular Risk
ETOPOSIDE	Myelosuppression Risk
FAT EMULSION, INTRAVENOUS	Use With Caution in Infants
FELBAMATE	Aplastic Anemia; liver failure risk
FENOPROFEN	NSAID Cardiovascular Risk
FENTANYL	Buccal tablets, nasal spray, and lozenges are only for management of breakthrough pain in opioid-tolerant patients.
FENTANYL TRANSDERMAL	Fentanyl patches to be used for chronic pain only
FLECAINIDE	Cardiovascular Risk
FLOXURIDINE	Hematological Risk
FLUCYTOSINE	Hepatic, hematolotical risks; caution in renal impairment
FLUDARABINE	Neurotoxicity, risk of hemolytic anemia
FLUMAZENIL	Seizure Risk
FLUOROURACIL	Hematologic Risk
FLUOXETINE	Suicidal Ideation
FLUPHENAZINE	Increased risk of mortality in elderly
FLURAZEPAM - NONFORMULARY	Risk From Concomitant Use With Opioids
FLURBIPROFEN	NSAID Cardiovascular Risk
FLUTAMIDE	Hepatic Failure Risk
FLUTICASONE PROPORIONATE-SALMETEROL: NONFORMULARY	Increase in asthma-related deaths
FLUVOXAMINE	Suicidal Ideation
FONDAPARINUX	Spinal/Epidural Hematoma Risk
FORMOTEROL	Increased risk of death
FOSCARNET	Nephrotoxicity; seizure risk
FOSINOPRIL (NONFORMULARY)	Pregnancy
FUROSEMIDE	Profound Diuresis
GADOBUTROL - RESTRICTED	Increased risk for NSF in patients with impaired renal function
GALLIUM NITRATE	Nephrotoxicity
GANCICLOVIR	Hematological Risk
GEMTUZUMAB	Myelosuppression; hepatotoxicity; hypersensitivity/anaphylaxis risk
GENTAMICIN	Neurotoxicity/Nephrotoxicity
GLYBURIDE-METFORMIN	Lactic Acidosis
GOLD SODIUM THIOMALATE	Experienced physician
HALOPERIDOL	Increased risk of mortality in elderly
HEPARIN	Spinal/epidural hematoma risk
HYDROCHLOROTHIAZIDE-TRIAMTERENE	Risk of hyperkalemia
HYDROCHLOROTHIAZIDE-VALSARTAN	Pregnancy
HYDROMORPHONE	Potential for abuse and respiratory depression
HYDROXYCHLOROQUINE	Information leaflet for physicians
HYDROXYUREA	Close supervision of patient
IBUPROFEN	NSAID Cardiovascular Risk
IBUTILIDE	Potentially fatal arrhythmias
IDARUBICIN	Extravasation; cardiac, myelosuppression risk
IFOSFAMIDE	Urotoxicity, neurotoxicity, myelosuppression risk
IMIPRAMINE	Suicidal ideation
IMMUNE GLOBULIN INTRAVENOUS	Risk of renal failure
INDOMETHACIN	NSAID Cardiovascular Risk
INFLIXIMAB	Opportunistic infection risk
INTERFERON ALFA-2A	Neuropsychiatric Risk
INTERFERON ALFA-2B	Neuropsychiatric Risk
IRBESARTAN (NONFORMULARY)	Pregnancy
IRBESARTAN-HYDROCHLOROTHIAZIDE	Pregnancy
IRINOTECAN	Severe diarrhea; myelosuppression risk
IRON DEXTRAN - NONFORMULARY	Anaphylaxis
ISOCARBOXAZID	Suicidal ideation
ISONIAZID	Hepatitis
ISOTRETINOIN	Teratogenicity
ITRACONAZOLE	CHF, multiple drug interactions
KANAMYCIN	Neurotoxicity/Nephrotoxicity
KETAMINE	Psychomimetic rand psycholotical reactions
KETOCONAZOLE	Hepatotoxicity, multiple drug interactions
KETOPROFEN	NSAID Cardiovascular Risk
KETOROLAC	NSAID Cardiovascular Risk
LAMIVUDINE	Lactic acidosis, hepatotoxicity
LAMIVUDINE-ZIDOVUDINE	Lactic Acidosis, hepatomegaly
LAMOTRIGINE	Serious dermatological reactions
LEFLUNOMIDE	Pregnancy
LEVOFLOXACIN	Increased risk of tendinitis and tendon rupture
LEVOTHYROXINE (IV IS RESTRICTED)	Not to be used for treatment of obesity
LIDOCAINE	Lidocaine viscous should not to be used to treat teething pain
LINDANE TOPICAL (NON FORMULARY)	Neurotoxicity
LIOTHYRONINE	Not for treatment of obesity
LIOTRIX	Not for treatment of obesity
LISDEXAMFETAMINE	Dependence/Diversion Potential
LISINOPRIL	Pregnancy
LISINOPRIL-HYDROCHLOROTHIAZIDE	Pregnancy
LITHIUM	Monitor serum Level
LOMUSTINE	Bone Marrow Suppression
LOPINAVIR/RITONAVIR	Significant Drug Interactions
LORAZEPAM	Risk From Concomitant Use With Opioids
LOSARTAN	Black Box Warning
LOXAPINE	Increased risk of mortality in elderly
LYMPHOCYTE IMMUNE GLOBULIN, ANTI-THYMOCYTE	Immunosuppression
MAPROTILINE	Suicide Ideation
MECHLORETHAMINE	Extravasation Risk
MEDROXYPROGESTERONE	Bone Loss
MELOXICAM	Cardiovascular Risk
MELPHALAN	Bone marrow suppression; hypersensitivity/anaphylaxis risk
MEPERIDINE - ORAL FORMULATIONS ARE NONFORMULARY	Addiction, Abuse, and Misuse; Life -Threatening Respiratory Depression; Neonatal Opioid Withdrawal Syndrome; Cytoshrome P450 3A4 interaction; Risks from Concomitant Use with CNS Depresssants and Monoamine Oxidase (MOA) Inhibi
MERCAPTOPURINE	Established diagnosis
METFORMIN	Lactic acidosis
METHACHOLINE	Experienced physician
METHADONE	Respiratory Depression/QT interval prolongation
METHAMPHETAMINE	Dependence/Diversion Potential
METHOHEXITAL	Continuous Monitoring of respiratory and cardiac function advised
METHOTREXATE	Hematologic and, pulmonary risks, renal toxicity
METHYLENE BLUE	Serotonin Syndrome with Concomitant Use of Serotonergic Drugs
METHYLPHENIDATE	Psychiatric effects
METRONIDAZOLE	Carcinogenic
MEXILETINE	For use in life threatening ventricular arrhythmias only
MIDAZOLAM	Respiratory depression/Arrest
MIDODRINE	Hypertension Risk
MINOXIDIL	Hypotensive Risk with oral therapy
MIRTAZAPINE	Suicidal ideation
MISOPROSTOL	Pregnancy Risk
MITOMYCIN	Hematologic Risk
MITOTANE	Adrenal Suppression Risk
MITOXANTRONE	Cardiotoxicity, hematologic, extravasation risks
MOEXIPRIL (NONFORMULARY)	Pregnancy
MOLINDONE	Increased risk of mortality in elderly
MORPHINE	Avinza: Alcohol use may result in rapid release of morphine
MORPHINE INJECTION	Narcan/resusitative equipment available upon initiation
MOXIFLOXACIN - NONFORMULARY	Increased risk of tendinitis and tendon rupture
MYCOPHENOLATE	Lymphoma and infections risks
NABUMETONE	Cardiovascular Risk
NADOLOL	Abrupt Withdrawal
NALTREXONE	Hepatotoxicity
NANDROLONE	Hepatic toxicity/Blood lipid Changes
NAPROXEN	Cardiovascular Risk
NATALIZUMAB	Progressive Multifocal Leukoencephalopathy (PML) and TOUCH distribution program
NEFAZODONE	Hepatic Failure Risk
NEOMYCIN	Neurotoxicity/Nephrotoxicity
NEVIRAPINE	Hepatic Toxicity, Dermal Reaction Risk
NIMODIPINE	Not to be administered IV
NITROPRUSSIDE	Hypotension, Risk of Cyanide Toxicity
NOREPINEPHRINE	Extravasation
NORFLOXACIN - NONFORMULARY	Increased risk of tendinitis and tendon rupture
NORTRIPTYLINE	Suicidal Ideation
OFLOXACIN - NONFORMULARY	Increased risk of tendinitis and tendon rupture
OLANZAPINE	Increased mortality in the elderly
OLMESARTAN (NONFORMULARY)	Pregnancy
OMALIZUMAB	Anaphylaxis
OPRELVEKIN	Anaphylaxis
OXALIPLATIN	Anaphylactic reaction risk
OXANDROLONE	Hepatic toxicity/Blood lipid Changes
OXAZEPAM	Risk From Concomitant Use With Opioids
OXYCODONE	Controlled Release not for prn use
OXYMORPHONE	Abuse/Misuse potential
OXYTOCIN	Use in elective induction
PACLITAXEL	Due tor risk of hypersensitivity/anaphylaxis premedicate all patients
PACLITAXEL PROTEIN-BOUND	Bone marrow suppression
PALIPERIDONE	Increased risk of mortality in elderly
PANCURONIUM	Requires trained personnel
PAROXETINE	Suicidal ideation
PEN G BENZATHINE/PROCAINE COMBINED	Do not administer IV
PENICILLAMINE	Use with caution
PENICILLIN G BENZATHINE	Do not administer IV
PENTAZOCINE/NALOXONE	Oral Use only
PERINDOPRIL (NONFORMULARY)	Pregnancy
PERPHENAZINE	Increased mortality in the elderly
PHENELZINE	Suicidal ideation
PHENYLEPHRINE INFUSION	injection: Physician should be familiar with package insert
PHENYTOIN	Cardiovascular risk associated with rapid infusion
PHYTONADIONE	Caution with IV infusion
PIMECROLIMUS TOPICAL	Long term use
PIOGLITAZONE	Cardiovascular Risk
PIOGLITAZONE-GLIMEPIRIDE	Cardiovascular Risk
PIPECURONIUM	Administration via trained personnel
PIROXICAM	Cardiovascular Risk
PNEUMOCOCCAL 7-VALENT VACCINE
PRAMLINTIDE	Possibility of severe hypoglycemia
PRASUGEL	Bleeding Risk
PRIMAQUINE	Experienced physicians only
PROCAINAMIDE	Hematologic, Cardiac Risks
PROCARBAZINE	Experienced physician
PROCHLORPERAZINE	Increased mortality in the elderly
PROGESTERONE	Increased risk of cardiovascular disorders, breast cancer, and dementia when used with estrogen
PROMETHAZINE	Not to be used in patients less than 2 years old
PROPAFENONE	Use in life-threatening arrhythmias only
PROPRANOLOL	Abrupt Discontinuation
PROPYLTHIOURACIL	Severe liver injury
PROTAMINE	Cardiovascular effects
PROTHROMBIN COMPLEX CONCENTRATE (HUMAN) - 4F-PCC	Arterial and venous thromboembolic complications
PROTRIPTYLINE	Suicidal ideation
QUAZEPAM - NONFORMULARY	Risk From Concomitant Use With Opioids
QUETIAPINE	Increased mortality in the elderly
QUINAPRIL (NONFORMULARY)	Pregnancy
QUINIDINE	Non-life threatening arrhythmia use
QUININE	No benefit in treatment/prevention of nocturnal leg cramps; risk of hematologic reactions
RALOXIFENE	Increased risk of thromboembolism and death from stroke
RAMIPRIL (NONFORMULARY)	Pregnancy
RASBURICASE	Anaphylaxis; hemolysis; Methemoglobinemia
RIBAVIRIN	Inhalation: deterioration in respiratory function
RISPERIDONE	Increased mortality in the elderly
RITONAVIR	Significant Drug interactions
RITUXIMAB	Fatal infusion reaction; tumor lysis syndrome risk
RIVAROXABAN	Premature discontinuation increases the risk of thrombotic events
ROSIGLITAZONE	Cardiovascular Risk
ROSIGLITAZONE-GLIMEPIRIDE (NONFORMULARY)	Cardiovascular Risk
ROSIGLITAZONE-METFORMIN (NONFORMULARY)	Lactic Acidosis
SALMETEROL	Increase in Asthma related deaths
SALSALATE	Cardiovascular Risk
SAQUINAVIR	Different brands are not interchangable
SELEGILINE	Suicidal Ideation
SERTRALINE	Suicidal Ideation
SIROLIMUS	Fatal bronchial anastomotic dihisence; fatal hepatic thrombosis risk
SODIUM BIPHOSPHATE-SODIUM PHOSPHATE	Acute Po4 nephropathy associated with oral product
SOTALOL	Dose adjustment in renal insuffiency
SPIRONOLACTONE	Chronic use
STAVUDINE	Pancreatitis, lactis acidosis, hepatomegaly
STREPTOZOCIN	Experienced physician; nephrotoxicity
SUCCINYLCHOLINE	Must be administered by trained personnel
SUFENTANIL	Addiction, Abuse, and Misuse
SULINDAC	NSAID Cardiovascular Risk
TACROLIMUS	Lymphoma, increased susceptibility to infection
TACROLIMUS TOPICAL	Long term safety not established
TAMOXIFEN	Stroke, pulmonary embolism, uterine malignancy risk
TELMISARTAN (NONFORMULARY)	Injury/death to developing fetus
TEMAZEPAM	Risk From Concomitant Use With Opioids
TENOFOVIR	Lactic Acidosis; hepatomegaly
TERBUTALINE	FDA warns that terbutaline should not be used for prevention or prolonged treatment of preterm labor
TERIPARATIDE	Osteosarcoma risk
TESTOSTERONE	Secondary exposure to testosterone gel
THALIDOMIDE	Pregnancy
THIORIDAZINE	QTC prolongation
THIOTHIXENE	Increased mortality in the elderly
THROMBIN TOPICAL	Hemostasis abnormalities
THYROID DESICCATED	Use in obesity
TICLOPIDINE	Hematological Risk
TIGECYCLINE - NONFORMULARY	All cause mortality
TIMOLOL	Abrupt Discontinuation Not Advised
TIZANIDINE	Capsules and tablets are not pharmacokinetic equivalents
TOBRAMYCIN - NONFORMULARY	Neurotoxicity/Nephrotoxicity
TOLCAPONE	Hepatotoxicity
TOLMETIN	NSAID cardiovascular Risk
TOLVAPTAN - RESTRICTED	Should be initiated and re-initiated in a hospital where serum Na can be monitored
TOPOTECAN	Infection Risk
TRAMADOL	Addiction , Abuse, and Misuse; Life-Threatening Respiratory Depression; Accidential Ingestion; Neonatal Opioid Withdrawal Syndrome; Interation with Drugs Affecting Cytochrome P450 Isoenzymes; and Risks From Concomitant Use With CNS Depressants
TRANDOLAPRIL (NONFORMULARY)	Pregnancy
TRANYLCYPROMINE	Suicidal Ideation
TRASTUZUMAB	Cardiomyopathy, hypersensitivity reaction risk
TRAZODONE	Suicidal Ideation
TRETINOIN	Leukocytosis; retinoic acid-APL syndrome
TRIAZOLAM	Risk From Concomitant Use With Opioids
TRIFLUOPERAZINE	Increased risk of mortality in elderly
TRIMIPRAMINE	Suicidal Ideation
VALPROIC ACID	Hepatotoxicity; Pancreatitis; Teratogenicity Risk
VALSARTAN	Pregnancy
VARENICLINE	Serious neuropsychiatric effects
VECURONIUM	Administration by Trained Personnel
VENLAFAXINE	Suicidal Ideation
VILAZODONE - NON FORMULARY	Suicidality
VINBLASTINE	IV use only; Granulocytopenia; extravasation risk
VINCRISTINE	IV use only; Granulocytopenia; Extravasation risk
VINORELBINE	IV use only; Granulocytopenia; Extravasation Risk
WARFARIN	Bleeding Risk
ZIDOVUDINE	Hematological, myopathy, lactic acidosis, hepatomegaly risk
ZIPRASIDONE	Increased mortality in the elderly
ZURANOLONE	Impaired Ability to Drive or Engage in Other Potentially Hazardous Activities

This site is intended for the staff of Genesis Health System.
While others may view accessible pages, Genesis Health System makes no warranty, express or implied,
as to the use of this information outside of Genesis Health System.